Stock & Company Details
Celcuity Inc $CELC
Price:
N/A
N/A
49M
$3.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-17.79
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
CELC technical indicators
Latest Celcuity Inc (CELC) indicator readings as of 2026-10-29.
CELC's 14-day RSI is 49.6, in neutral territory. At $69.30 it is trading 31.3% below its 200-day moving average of $100.86, and below its 50-day average of $78.10. Price sits in the middle of its Bollinger Bands ($55.84 to $74.81). ADX reads 27.5, indicating a trending market.
Overview
Celcuity Inc is a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications. The company's therapeutic candidate is gedatolisib, a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all Class I isoforms of PI3K and the mammalian target of rapamycin (mTOR).
Finance Bot
Ask your questions
Start by typing a question below.
